PubMed Health treatment related to Deficiency Anemia: 63
Treatment for anemia depends on the type, cause, and severity of the condition. Treatments may include dietary changes or supplements, medicines, procedures, or surgery to treat blood loss.
Drugs for Deficiency Anemia (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):
(show top 50)
(show all 681)
# |
|
Name |
Status |
Phase |
Clinical Trials |
Cas Number |
PubChem Id |
1 |
|
Iron protein succinylate |
Approved, Investigational |
Phase 4 |
|
250705-13-6 |
|
2 |
|
Proguanil |
Approved |
Phase 4 |
|
500-92-5 |
4923 6178111 |
Synonyms:
1-(p-Chlorophenyl)-5-isopropylbiguanide
Chlorguanide
Chloroguanide
N-(4-Chlorophenyl)-n'-(isopropyl)-imidodicarbonimidic diamide
|
PROGUANIL
Proguanile
Proguanilo
Proguanilum
|
|
3 |
|
Posaconazole |
Approved, Investigational, Vet_approved |
Phase 4 |
|
171228-49-2 |
147912 |
Synonyms:
|
4 |
|
Halofantrine |
Approved |
Phase 4 |
|
69756-53-2 |
37393 |
Synonyms:
1-(1,3-dichloro-6-Trifluoromethyl-9-phenanthryl)-3-di(N-butyl)aminopropanol HCL
Halfan
Halfan®|WR-171669
Halofantrina
|
Halofantrine
Halofantrine hydrochloride
Halofantrinum
|
|
5 |
|
Artenimol |
Approved, Experimental, Investigational |
Phase 4 |
|
71939-50-9 |
540327 |
Synonyms:
3alpha-Hydroxydeoxydihydroartemisinin
8alpha-Hydroxydeoxyartemisinin
9alpha-Hydroxydeoxyartemisinin
ARTEMETHER RELATED COMPOUND A
ARTENIMOL
beta-Dihydroartemisinin
DIHYDROARTEMISININ
|
Dihydroartemisinine
Dihydroqinghaosu
Dihydroquinghaosu
Dihydroquinghaosu, (3R-(3alpha,5abeta,6beta,8abeta,9alpha,10alpha,12alpha,12ar*))-isomer
Dihydroquinghaosu, (3R-(3alpha,5abeta,6beta,8abeta,9alpha,10beta,12alpha,12ar*))-isomer
GNF-PF-5634
|
|
6 |
|
Piperaquine |
Approved, Experimental, Investigational |
Phase 4 |
|
4085-31-8 |
|
Synonyms:
1,3-Bis(1-(7-chloro-4'-quinolyl)-4'-piperazinyl)propane
1,3-Bis(4-(7'-chloro-4'-quinoline)-1-piperazine)
1,3-Bis[4-(7-chloroquinolin-4-yl)piperazin-1-yl]propane
|
PIPERAQUINE
Piperaquinoline
|
|
7 |
|
Cinacalcet |
Approved |
Phase 4 |
|
226256-56-0 |
156419 |
Synonyms:
(R)-alpha-Methyl-N-[3-[3-(trifluoromethyl)phenyl]propyl]-1-naphthalenemethane amine
(R)-a-Methyl-N-[3-[3-(trifluoromethyl)phenyl]propyl]-1-naphthalenemethane amine
(R)-Α-methyl-N-[3-[3-(trifluoromethyl)phenyl]propyl]-1-naphthalenemethane amine
073, AMG
1493, KRN
alpha-Methyl-N-(3-(3-(trifluoromethyl)phenyl)propyl)-1-naphthalenemethanamine, (alphar)-hydrochloride
AMG 073
AMG-073
AMG-073|Mimpara®|Sensipar®
|
CINACALCET
Cinacalcet hydrochloride
CNC
Hydrochloride, cinacalcet
KRN1493
KRN-1493
Mimpara
N-((1R)-1-(Naphthalen-1-yl)ethyl)-3-(3-(trifluoromethyl)phenyl)propan-1-amine
Sensipar
|
|
8 |
|
Peginterferon alfa-2a |
Approved, Investigational |
Phase 4 |
|
198153-51-4 |
|
Synonyms:
PEGASYS
PEG-IFN alfa-2A
PEG-Interferon alfa-2A
PEGINTERFERON ALFA-2A
PEGYLATED IFN-ALPHA-2A
Pegylated Interfeaon alfa-2A
|
Pegylated interferon alfa-2a
Pegylated interferon alpha-2a
Pegylated-interferon alfa 2a
RO-258310000
ROFERON-A
|
|
9 |
|
Amodiaquine |
Approved, Investigational |
Phase 4 |
|
86-42-0 |
2165 |
Synonyms:
Amodiachin
Amodiaquin
Amodiaquina
Amodiaquine
Amodiaquine hydrochloride
Amodiaquine usp24
Amodiaquine, ring-closed
Amodiaquinum
Basoquin
CAM-AQ1
CAM-AQI
Camochin
|
Camoquin
Camoquin HCL
Camoquinal
Camoquine
Flavoquin
Flavoquine
GNF-PF-5648
Hydrochloride, amodiaquine
Miaquin
NSC-13453
Roussel brand OF amodiaquine hydrochloride
SJ000110703
|
|
10 |
|
Artesunate |
Approved, Investigational |
Phase 4 |
|
88495-63-0 |
6917864 5464098 |
Synonyms:
(3R,5AS,6R,8AS,9R,10S,12R,12AR)-DECAHYDRO-3,6,9-TRIMETHYL-3,12-EPOXY-12H-PYRANO(4,3-J)-1,2-BENZODIOXEPIN-10-OL HYDROGEN SUCCINATE
ARSUMAX
ARTESUNATE
Artesunato
Artesunatum
Artesunic acid
AS
Butanedioate, 1-[(3R,5as,6R,8as,9R,10S,12R,12ar)-decahydro-3,6,9-trimethyl-3,12-epoxy-12H-pyrano[4,3-J]-1,2-benzodioxepin-10-yl] ester
Butanedioic acid, 1-[(3R,5as,6R,8as,9R,10S,12R,12ar)-decahydro-3,6,9-trimethyl-3,12-epoxy-12H-pyrano[4,3-J]-1,2-benzodioxepin-10-yl] ester
Dihydroartemisinin, succinyl
|
Dihydroartemisinine 12 alpha succinate
Dihydroartemisinine-12-alpha-succinate
Dihydroqinghasu hemsuccinate
Dihydroqinghasu hemsuccinic acid
Malacef
Malartin
NSC-712571
Sodium artesunate
Succinyl dihydroartemisinin
|
|
11 |
|
Ferrous gluconate |
Approved |
Phase 4 |
|
299-29-6 |
|
Synonyms:
D-gluconic acid, iron(2+) salt (2:1)
Ferric Gluconate
Ferrous gluconate anhydrous
|
Iron(2+) gluconate (1:2)
Iron(II) gluconate, anhydrous
|
|
12 |
|
Carbetocin |
Approved, Investigational |
Phase 4 |
|
37025-55-1 |
16681432 |
Synonyms:
1-Butanoate-2-(O-methyl-L-tyrosine)-1-carbaoxytocin
1-Butanoic acid-2-(O-methyl-L-tyrosine)-1-carbaoxytocin
1-Butyrate-2-(3-(p-methoxyphenyl)-L-alanine)oxytocin
1-Butyric acid-2-(3-(p-methoxyphenyl)-L-alanine)oxytocin
1-Deamino-1-monocarba-2-(tyr(ome))-oxytocin
CARBETOCIN
Carbetocina
Carbetocino
|
Carbetocinum
Dcomot
Deamino-2-O-methyltyrosine-1-carbaoxytocin
Depotocin
LV-101
PABAL
Pabal®
|
|
13 |
|
Methylergometrine |
Approved |
Phase 4 |
|
113-42-8 |
8226 |
Synonyms:
9,10-DIDEHYDRO-N-[1-(HYDROXYMETHYL)-PROPYL]-D-LYSERGAMIDE
D-LYSERGIC ACID 1-BUTANOLAMIDE
Ergotyl
MET827
Methergin
Méthergin
Methergine
Methergine®|methylergobasin
Methylergobasin
Methylergobasine
Methylergobrevin
|
Methylergometrin
Methylergometrine
MÉTHYLERGOMÉTRINE
Methylergometrine maleate
METHYLERGOMETRINUM
Methylergonovin
Methylergonovine
Methylergonovine maleate
METILERGOMETRINA
Metilergometrinio
Novartis brand OF methylergonovine maleate
|
|
14 |
|
Quinidine |
Approved, Investigational |
Phase 4 |
|
56-54-2, 130-95-0, 804-63-7 |
1065 441074 3034034 8549 |
Synonyms:
(−)-quinine
(-)-Quinine
(+)-Quinidine
(8R,9S)-Quinidine
(8S,9R)-Quinine
(R)-(−)-quinine
(R)-(-)-Quinine
(R)-(6-Methoxyquinolin-4-yl)((2S,4S,8R)-8-vinylquinuclidin-2-yl)methanol
(R)-(6-METHOXY-QUINOLIN-4-YL)-((2S,5S)-5-VINYL-1-AZA-BICYCLO[2.2.2]OCT-2-YL)-METHANOL
(R)-(6-Methoxyquinolin-4-yl)((3S,4R,7S)-3-vinylquinuclidin-7-yl)methanol
(S)-(6-METHOXY-4-QUINOLYL)-[(2R,4S,5R)-5-VINYL-2-QUINUCLIDINYL]METHANOL
(S)-(6-METHOXY-4-QUINOLYL)-[(2R,4S,5R)-5-VINYLQUINUCLIDIN-2-YL]METHANOL
(S)-(6-Methoxy-quinolin-4-yl)-((2R,5R)-5-vinyl-1-aza-bicyclo[2.2.2]oct-2-yl)-methanol
(S)-(6-Methoxyquinolin-4-yl)((2R,5R)-5-vinylquinuclidin-2-yl)methanol
(S)-[(4S,5R,7R)-5-ETHENYL-1-AZABICYCLO[2.2.2]OCTAN-7-YL]-(6-METHOXYQUINOLIN-4-YL)METHANOL
6-Methoxy-a-(5-vinyl-2-quinuclidinyl)-4-quinolinemethanol
6-Methoxy-alpha-(5-vinyl-2-quinuclidinyl)-4-quinolinemethanol
6'-Methoxycinchonidine
6'-Methoxycinchonine
6-Methoxy-α-(5-vinyl-2-quinuclidinyl)-4-quinolinemethanol
a-(6-Methoxy-4-quinolyl)-5-vinyl-2-quinuclidinemethanol
Adaquin
Aflukin
alpha-(6-Methoxy-4-quinolyl)-5-vinyl-2-quinuclidinemethanol
Alphapharm brand OF quinine sulfate
Apo quinidine
Apo-quinidine
Apotex brand OF quinidine sulfate
Aventis brand OF quinine bisulfate
beta-Quinine
Biquin Durules
Biquinate
Bisulfate, quinine
b-Quinine
Cardioquin
Chinidin
Chinidinum
Chinin
Chinine
Chininum
CIN-quin
Coccinine
Coco-Quinine
Conchinin
Conchinine
Conquinine
Duraquin
Fawns and mcallan brand OF quinidine sulfate
Fawns and mcallan brand OF quinine bisulfate
Fawns and mcallan brand OF quinine sulfate
Foy brand OF quinine sulfate
GNF-PF-506
GNF-Pf-506|Qualaquin®|Quinate®|quinine bisulphate|quinine sulfate
Hoechst brand OF quinine sulfate
Hydrochloride, quinine
Innotech brand OF quinine hydrochloride
Kinidin
Lafran brand OF quinine hydrochloride
Legatrim
|
Myoquin
Nelson brand OF quinidine sulfate
Novoquinidin
NSC-192949
Odan brand OF quinine sulfate
Pitayin
Pitayine
Plough brand OF quinine sulfate
Prosana brand OF quinine bisulfate
QUALAQUIN
Quinact
QUINAGLUTE
Quinaglute Dura-Tabs
Quinaglute®|Quinidex®|quinidine hydrochloride
Quinalan
Quinamm
QUINATE
Quinatime
Quinbisan
Quinbisul
Quincardine
Quindan
Quindine
Quinicardine
Quinidex
Quinidex Extentabs
Quinidina
QUINIDINE
Quinidine Gluconate
QUINIDINE HYDROCHLORIDE
Quinidine sulfate
Quinimax
Quinina
QUININE
Quinine bisulfate
QUININE BISULPHATE
Quinine Dab
Quinine hydrochloride
Quinine lafran
Quinine sulfate
Quinine sulphate
Quinine, anhydrous
Quinineanhydrous
Quinine-odan
Quinoctal
Quinoline alkaloid
Quinora
Quin-Release
Quinson
Quinsul
Robins brand OF quinidine sulfate
Strema
Sulfate, quinidine
Sulfate, quinine
Sulphate, quinine
Surquina
WR297608
Α-(6-methoxy-4-quinolyl)-5-vinyl-2-quinuclidinemethanol
Β-quinine
|
|
15 |
|
Artemether |
Approved |
Phase 4 |
|
71963-77-4 |
68911 9796294 |
Synonyms:
(1R,4S,5R,8S,9R,10S,12R,13R)-10-Methoxy-1,5,9-trimethyl-11,14,15,16-tetraoxatetracyclo[10.3.1.0^{4,13}.0^{8,13}]hexadecane
10-Methoxy-1,5,9-trimethyl-(1R,4S,5R,8S,9R,10S,12R,13R)-11,14,15,16-tetraoxatetracyclo[10.3.1.04,13.08,13]hexadecane
alpha Artemether
alpha-Artemether
ARM566
Artemetero
ARTEMETHER
Artemether, (3R-(3alpha,5abeta,6alpha,8abeta,9alpha,10beta,12beta,12ar*))-isomer
Artemether, (3R-(3alpha,5abeta,6beta,8aalpha,9alpha,10beta,12beta,12ar*))-isomer
Artemether, (3R-(3alpha,5abeta,6beta,8abeta,9alpha,10alpha,12beta,12ar*))-isomer
ARTEMETHERI
Artemetherum
Artemisininelactol methyl ether
Artenam
b-Artemether
b-Dihydroartemisinin methyl ether
|
beta Arthemeter
beta-Artemether
beta-Arthemeter
beta-Dihydroartemisinin methyl ether
DIHYDROARTEMISININ IMPURITY G
Dihydroartemisinin methyl ether
DIHYDROQINGHAOSU METHYL ETHER
Methyl-dihydroartemisinine
NSC-665970
O Methyldihydroartemisinine
O-Methyldihydroartemisinine
SM 224
SM-224
Β-artemether
Β-dihydroartemisinin methyl ether
|
|
16 |
|
Lumefantrine |
Approved |
Phase 4 |
|
82186-77-4 |
6437380 |
Synonyms:
(+-)-2,7-Dichloro-9-((Z)-p-chlorobenzylidene)-a-((dibutylamino)methyl)fluorene-4-methanol
(+-)-2,7-Dichloro-9-((Z)-p-chlorobenzylidene)-alpha-((dibutylamino)methyl)fluorene-4-methanol
(+-)-2,7-Dichloro-9-((Z)-p-chlorobenzylidene)-α-((dibutylamino)methyl)fluorene-4-methanol
(±)-2,7-Dichloro-9-((Z)-p-chlorobenzylidene)-α-((dibutylamino)methyl)fluorene-4-methanol
2-Dibutylamino-1-[2,7-dichloro-9-(4-chloro-benzylidene)-9H-fluoren-4-yl]-ethanol
2-Dibutylamino-1-{2,7-dichloro-9-[1-(4-chloro-phenyl)-meth-(Z)-ylidene]-9H-fluoren-4-yl}-ethanol
Benflumetol
|
Benflumetol, (-)-isomer
Benflumetol, (+)-isomer
Benflumetol, (+-)-isomer
CPG-56695
DL-Benflumelol
GNF-PF-1971
LUMEFANTRINE
|
|
17 |
|
Trimethoprim |
Approved, Vet_approved |
Phase 4 |
|
738-70-5 |
5578 |
Synonyms:
2,4-Diamino-5-(3,4,5-trimethoxybenzyl)pyrimidine
5-[(3,4,5-Trimethoxyphenyl)methyl]-2,4-pyrimidinediamine
BW-5672
BW-56-72
CO-Trimoxazole
IPRAL
LEDATRIM
MONOTRIM
NIH-204
NSC-106568
POLYTRIM
PRIMSOL
Proloprim
PROLOPRIN
|
SYRAPRIM
TCMDC-125538
TIEMPE
TMP
TRIMETHOPRIM
TRIMETHOPRIME
TRIMÉTHOPRIME
TRIMETHOPRIMUM
TRIMETOPRIMA
TRIMOGAL
TRIMOPAN
Trimpex
TRIMPEX 200
TRIPRIMIX 200
|
|
18 |
|
Sulfamethoxazole |
Approved |
Phase 4 |
|
723-46-6 |
5329 |
Synonyms:
3-(p-Aminobenzenesulfonamido)-5-methylisoxazole
3-(p-Aminophenylsulfonamido)-5-methylisoxazole
3-(p-Aminophenylsulphonamido)-5-methylisoxazole
3-(Para-aminophenylsulphonamido)-5-methylisoxazole
3-Sulfanilamido-5-methylisoxazole
3-Sulphanilamido-5-methylisoxazole
4-Amino-N-(5-methyl-1,2-oxazol-3-yl)benzenesulfonamide
4-Amino-N-(5-methyl-3-isoxazolyl)benzenesulfonamide
4-Amino-N-(5-methyl-3-isoxazolyl)-benzenesulfonamide
4-Amino-N-(5-methyl-3-isoxazolyl)benzenesulphonamide
5-Methyl-3-sulfanilamidoisoxazole
5-Methyl-3-sulfanylamidoisoxazole
5-Methyl-3-sulfonylamidoisoxazole
5-Methyl-3-sulphanil-amidoisoxazole
ACETYLSULFAMETHOXAZOLE
Apo-Sulfamethoxazole
Azo Gantanol
Azo-gantanol
Bactrim
Bactrimel
Gamazole
Gantanol
GANTANOL (TN)
GANTANOL-DS
Metoxal
N'-(5-methyl-3-isoxazole)sulfanilamide
N'-(5-methyl-3-isoxazolyl)sulfanilamide
N'-(5-methyl-3-isoxazolyl)-sulfanilamide
N'-(5-methylisoxazol-3-yl)sulphanilamide
N^1-(5-methyl-3-isoxazolyl)-sulfanilamide
N1-(5-Methyl-3-isoxazolyl)sulfanilamide
N1-(5-Methyl-3-isoxazolyl)-sulfanilamide
|
N1-(5-Methyl-3-isoxazolyl)sulphanilamide
Ndimethyl1-(5-methyl-3-isoxazolyl)-sulfanilamide
NSC-147832
Radonil
RO-42130
RO-4-2130
Septran
SIM
Simsinomin
Sinomin
SMX
SMZ
STX-608
Sulfamethalazole
Sulfamethoxazol
SULFAMETHOXAZOLE
SULFAMETHOXAZOLE SODIUM
Sulfamethoxazole(usan)
Sulfamethoxizole
Sulfamethylisoxazole
Sulfametoxazol
Sulfisomezole
Sulphamethalazole
Sulphamethoxazol
Sulphamethoxazole
Sulphamethoxazole BP 98
Sulpha-methoxizole
Sulphamethylisoxazole
Sulphisomezole
SUPHAMETHOXAZOLE
Trib
UROBAK
|
|
19 |
|
Hydromorphone |
Approved, Illicit |
Phase 4 |
|
466-99-9, 71-68-1 |
5284570 |
Synonyms:
(-)-(5R)-4,5-Epoxy-3-hydroxy-9alpha-methylmorphinan-6-one
(-)-(5R)-4,5-Epoxy-3-hydroxy-9a-methylmorphinan-6-one
(-)-(5R)-4,5-Epoxy-3-hydroxy-9α-methylmorphinan-6-one
4,5a-Epoxy-3-hydroxy-17-methyl-6-morphinanone
4,5alpha-Epoxy-3-hydroxy-17-methyl-6-morphinanone
4,5-Epoxy-3-hydroxy-17-methylmorphinan-6-one
4,5Α-epoxy-3-hydroxy-17-methyl-6-morphinanone
6-Deoxy-7,8-dihydro-6-oxomorphine
7,8-Dihydromorphinone
Dihydromorfinon
Dihydromorfinon [Czech]
Dihydromorphinone
Dilaudid
Dilaudid Oros
Dilaudid®|hydromorphone hydrochloride|Palladone®
DILAUDID-HP
DiMo
Dimorphone
Hidromorfona
|
Hidromorfona [INN-Spanish]
Hydromorfona
Hydromorfona [Spanish]
Hydromorphon
HYDROMORPHONE
Hydromorphone HCL
Hydromorphone hydrochloride
Hydromorphonum
Hydromorphonum [INN-Latin]
Hymorphan
Idromorfone
IDS-NH-004
Laudacon
Laudicon
N02AA03
Novolaudon
NSC-19046
Palladone
Paramorphan
|
|
20 |
|
Zoledronic acid |
Approved |
Phase 4 |
|
118072-93-8 |
68740 |
Synonyms:
(1-Hydroxy-2-(1H-imidazol-1-yl)ethylidene)bisphosphonate
(1-Hydroxy-2-(1H-imidazol-1-yl)ethylidene)bisphosphonic acid
(1-Hydroxy-2-imidazol-1-ylethylidene)diphosphonate
(1-Hydroxy-2-imidazol-1-ylethylidene)diphosphonic acid
2-(Imidazol-1-yl)-1-hydroxyethylidene-1,1-bisphosphonic acid
ácido zoledrónico
ACLASTA
Aclasta®|CGP-42446|CGP-42446A|Reclast®|zoledronate|Zometa®
ANHYDROUS ZOLEDRONIC ACID
CGP-42446
CGP-42446A
Novartis brand OF zoledronic acid
|
Reclast
ZERLINDA
ZOL
ZOL446
ZOLEDRONATE
Zoledronic acid
Zoledronic acid anhydrous
ZOLEDRONIC ACID HYDRATE
ZOLEDRONIC ACID MONOHYDRATE
ZOLEDRONIC ACID, ANHYDROUS
Zometa
Zometa Concentrate
|
|
21 |
|
Etonogestrel |
Approved, Investigational |
Phase 4 |
|
54048-10-1 |
6917715 |
Synonyms:
13-Ethyl-17-hydroxy-11-methylene-18,19-dinor-17alpha-pregn-4-en-20-yn-3-one
3-Ketodesogestrel
3-Keto-desogestrel
3-oxo Desogestrel
3-Oxodesogestrel
ETONOGESTREL
ÉTONOGESTREL
|
Etonogestrelum
Implanon
Nexplanon
Nourypharma brand OF 3-keto-desogestrel
ORG-3236
Organon brand OF 3-keto-desogestrel
|
|
22 |
|
Desogestrel |
Approved |
Phase 4 |
|
54024-22-5 |
40973 |
Synonyms:
13 Ethyl 11 methylene 18,19 dinor 17 alpha pregn 4 en 20 yn 17 ol
13-Ethyl-11-methylene-18,19-dinor-17 alpha-pregn-4-en-20-yn-17-ol
13-Ethyl-11-methylene-18,19-dinor-17alpha-pregn-4-en-20-yn-17-ol
13-Ethyl-11-methylene-18,19-dinor-17a-pregn-4-en-20-yn-17-ol
13-Ethyl-11-methylene-18,19-dinor-17α-pregn-4-en-20-yn-17-ol
AIZEA
alpha-Pregn-4-en-20-yn-17-ol, 13-ethyl-11-methylene-18,19-dinor-17
Cerazette
CERELLE
Desogestrel
|
Désogestrel
Desogestrelum
DESOMONO
FEANOLLA
Marvelon
NACREZ
ORG-2969
Organon brand OF desogestrel
ZELLETA
|
|
23 |
|
Iron isomaltoside 1000 |
Approved, Investigational |
Phase 4 |
|
1370654-58-2 |
|
Synonyms:
|
24 |
|
Lactitol |
Approved, Investigational |
Phase 4 |
|
585-86-4 |
157355 |
Synonyms:
4-O-beta-D-Galactopyranosyl-D-glucitol
4-O-β-D-Galactopyranosyl-D-glucitol
D-Lactitol
Emportal
Importal
Lactitol
|
Lactitolum
Neda lactiv importal
Oponaf
Pizensy
WURCS=2.0/2,2,1/[H2122H][a2112h-1b_1-5]/1-2/a4-b1
|
|
25 |
|
Luspatercept |
Approved, Investigational |
Phase 4 |
|
1373715-00-4 |
|
Synonyms:
|
26 |
|
Valsartan |
Approved, Investigational |
Phase 4 |
|
137862-53-4 |
60846 |
Synonyms:
(S)-N-Valeryl-N-{[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]-methyl}-valine
CGP-48933
CGP-48933|Diovan®|Prexxartan® (oral solution)
Diovan
EXFORGE
Kalpress
Miten
N-(p-(O-1H-Tetrazol-5-ylphenyl)benzyl)-N-valeryl-L-valine
Nisis
|
N-Pentanoyl-N-{[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl}-L-valine
N-Valeryl-N-((2'-(1H-tetrazol-5-yl)biphenyl-4-yl)methyl)valine
PREXXARTAN
Provas
Tareg
VAL489
Vals
VALSARTAN
|
|
27 |
|
Dapagliflozin |
Approved |
Phase 4 |
|
461432-26-8 |
9887712 |
Synonyms:
(2S,3R,4R,5S,6R)-2-(4-Chloro-3-(4-ethoxybenzyl)phenyl)-6- (hydroxymethyl)tetrahydro-2H-pyran-3,4,5-triol
BMS-512148
BMS-512148|Farxiga®|Forxiga®
BMS-512148-05
|
Dapagliflozin
Dapagliflozina
FARXIGA
FORXIGA
|
|
28 |
|
Albendazole |
Approved, Vet_approved |
Phase 4 |
|
54965-21-8 |
2082 |
Synonyms:
(5-(Propylthio)-1H-benzimidazol-2-yl)carbamate methyl ester
(5-(Propylthio)-1H-benzimidazol-2-yl)carbamic acid methyl ester
5-(Propylthio)-2-carbomethoxyaminobenzimidazole
Albendazol
Albendazole
Albendazole armstrong brand
Albendazole diba brand
Albendazole fustery brand
Albendazole hormona brand
Albendazole liferpal brand
Albendazole monohydrochloride
Albendazole noé-socopharm brand
Albendazole pfizer brand
Albendazole sanicoopa brand
Albendazole valdecasas brand
Albendazolum
Albendoral
Albenza
Andazol
Armstrong brand OF albendazole
Bendapar
Bilutac
Diba brand OF albendazole
Digezanol
Disthelm
Disthelm, mediamix V
Endoplus
Eskazole
Fustery brand OF albendazole
|
Gascop
Hormona brand OF albendazole
Liferpal brand OF albendazole
Lurdex
Mediamix V disthelm
Metiazol
Monohydrochloride, albendazole
Noé socopharm brand OF albendazole
Noé-socopharm brand OF albendazole
NSC-220008
O-Methyl N-(5-(propylthio)-2-benzimidazolyl)carbamate
O-Methyl N-(5-(propylthio)-2-benzimidazolyl)carbamic acid
Pfizer brand OF albendazole
Proftril
RICOBENDAZOLE
RYCOBENDAZOLE
Sanicoopa brand OF albendazole
SK And F 62979
SK And F62979
SK And F-62979
SK&F 62979
SK&F-62979
SmithKline beecham brand OF albendazole
V Disthelm, mediamix
Valbazen
Valdecasas brand OF albendazole
ZENTAL
Zentel
|
|
29 |
|
Ferrous succinate |
Approved |
Phase 4 |
|
10030-90-7 |
|
Synonyms:
|
30 |
|
Deferasirox |
Approved, Investigational |
Phase 4 |
|
201530-41-8 |
214348 5493381 |
Synonyms:
4-(3,5-Bis-(2-hydroxyphenyl)-(1,2,4)-triazol-1-yl)benzoic acid
DEFERASIROX
Deferasiroxum
Deferasiroxum [inn-latin]
Exjade
ICL 670
ICL 670a
|
ICL670
ICL-670
ICL670a
ICL-670a
Jadenu
JADENU SPRINKLE
|
|
31 |
|
Ferrous fumarate |
Approved |
Phase 4 |
|
141-01-5 |
|
Synonyms:
|
32 |
|
Ferric maltol |
Approved |
Phase 4 |
|
33725-54-1 |
|
Synonyms:
Accrufer
Ferric maltol
Iron (III) maltol
|
Iron(3+) ion tris(2-methyl-4-oxo-4H-pyran-3-olic acid)
Iron(3+) tris(2-methyl-4-oxo-4H-pyran-3-olate)
|
|
33 |
|
Deferiprone |
Approved |
Phase 4 |
|
30652-11-0 |
2972 |
Synonyms:
1,2 Dimethyl 3 hydroxy 4 pyridinone
1,2 Dimethyl 3 hydroxypyrid 4 one
1,2 Dimethyl 3 hydroxypyridin 4 one
1,2-Dimethyl-3-hydroxy-4-pyridinone
1,2-Dimethyl-3-hydroxypyrid-4-one
1,2-Dimethyl-3-hydroxypyridin-4-one
3 Hydroxy 1,2 dimethyl 4 pyridinone
3-Hydroxy-1,2-dimethyl-4(1H)-pyridone
3-Hydroxy-1,2-dimethyl-4-pyridinone
APO-066
APO-66
CP20
CP-20
DEFERIPRON
DEFERIPRONA
DEFERIPRONE
DÉFÉRIPRONE
|
DEFERIPRONI
DEFERIPRONUM
DEFERYPRON
DIMETHYLHYDROXYPYRIDONE
DMOHPO
DN-18001AF
DN-180-01-AF
Ferriprox
HDMPP
HDMPP CPD
HDPP
L1
L-1
L1 Oral chelate
PL1
PL-1
|
|
34 |
|
Ribavirin |
Approved |
Phase 4 |
|
36791-04-5 |
37542 |
Synonyms:
1-b-D-Ribofuranosyl-1,2,4-triazole-3-carboxamide
1-b-D-Ribofuranosyl-1H-1,2,4-triazole-3-carboxamide
1-beta-D-Ribofuranosyl-1,2,4-triazole-3-carboxamide
1-beta-D-Ribofuranosyl-1H-1,2,4-triazole-3-carboxamide
1-Β-D-ribofuranosyl-1,2,4-triazole-3-carboxamide
1-Β-D-ribofuranosyl-1H-1,2,4-triazole-3-carboxamide
Copegus
Copegus®|RBV|Rebetol®|ribofluranosyl carboxamide|Virazole®
Dermatech brand OF ribavirin
Essex brand OF ribavirin
Grossman brand OF ribavirin
ICN brand OF ribavirin
Merck brand OF ribavirin
NSC-163039
Pfizer brand OF ribavirin
RBV
Rebetol
Rebetron
Rebretron
Ribamide
Ribamidil
Ribamidyl
RIBAPAK
Ribasphere
RIBAV
RIBAVARIN
Ribavirin
|
Ribavirin Capsules
Ribavirin merck brand
Ribavirin Triphosphate
Ribavirina
Ribavirina [INN-Spanish]
Ribavirine
Ribavirine [INN-French]
Ribavirin-TP
Ribavirinum
Ribavirinum [INN-Latin]
RIBOFLURANOSYL CARBOXAMIDE
Ribovirin
RTC
RTCA
RTP
SCH 18908
SCH-18908
Three rivers pharmaceuticals brand OF ribavirin
Tribavirin
Varazid
Vilona
VIRAMID
Viramide
VIRAZID
Virazide
Virazole
Virazole 5'-triphosphate
|
|
35 |
|
Ketorolac |
Approved |
Phase 4 |
|
74103-06-3, 66635-83-4 |
3826 |
Synonyms:
(+-)-5-Benzoyl-2,3-dihydro-1H-pyrrolizine-1-carboxylate
(+-)-5-Benzoyl-2,3-dihydro-1H-pyrrolizine-1-carboxylic acid
(+-)-Ketorolac
ACULAR
Acular LS
Acular Preservative Free
Acular®|Toradol®
Ketoralac
Ketorolac
|
Kétorolac
Ketorolac tromethamine
Ketorolaco
Ketorolaco [Spanish]
Ketorolacum
Ketorolacum [Latin]
rac-Ketorolac
Toradol
|
|
36 |
|
Ibuprofen |
Approved |
Phase 4 |
|
15687-27-1 |
3672 |
Synonyms:
(+-)-2-(p-Isobutylphenyl)propionate
(+-)-2-(p-Isobutylphenyl)propionic acid
(+-)-alpha-Methyl-4-(2-methylpropyl)benzeneacetate
(+-)-alpha-Methyl-4-(2-methylpropyl)benzeneacetic acid
(+-)-a-Methyl-4-(2-methylpropyl)benzeneacetate
(+-)-a-Methyl-4-(2-methylpropyl)benzeneacetic acid
(+-)-Ibuprofen
(+-)-p-Isobutylhydratropate
(+-)-p-Isobutylhydratropic acid
(+-)-Α-methyl-4-(2-methylpropyl)benzeneacetate
(+-)-Α-methyl-4-(2-methylpropyl)benzeneacetic acid
(±)-2-(P-ISOBUTYLPHENYL)PROPIONIC ACID
(±)-IBUPROFEN
(±)-P-ISOBUTYLHYDRATROPIC ACID
(±)-Α-METHYL-4-(2-METHYLPROPYL)BENZENEACETIC ACID
(4-Isobutylphenyl)-alpha-methylacetate
(4-Isobutylphenyl)-alpha-methylacetic acid
(4-Isobutylphenyl)-a-methylacetate
(4-Isobutylphenyl)-a-methylacetic acid
(4-Isobutylphenyl)-α-methylacetate
(4-Isobutylphenyl)-α-methylacetic acid
(RS)-Ibuprofen
2-(4-Isobutylphenyl)propanoate
2-(4-Isobutylphenyl)propanoic acid
4-Isobutylhydratropate
4-Isobutylhydratropic acid
a-(4-Isobutylphenyl)propionate
a-(4-Isobutylphenyl)propionic acid
a-(p-Isobutylphenyl)propionate
a-(p-Isobutylphenyl)propionic acid
ACHES-N-PAIN
Actiprofen
Adran
Advil
ADVIL LIQUI-GELS
ADVIL MIGRAINE LIQUI-GELS
Advil®|Brufen®|ibuprofen lysine|ibuprofen sodium|Motrin®|Nurofen®|U-18573
alpha-(4-Isobutylphenyl)propionate
alpha-(4-Isobutylphenyl)propionic acid
alpha-(p-Isobutylphenyl)propionate
alpha-(p-Isobutylphenyl)propionic acid
alpha-Methyl-4-(2-methylpropyl)benzeneacetic acid
alpha-p-Isobutylphenylpropionate
alpha-p-Isobutylphenylpropionic acid
Aluminum salt ibuprofen
Amersol
Amibufen
ANADIN JOINT PAIN
ANADIN LIQUIFAST
ANADIN PERIOD PAIN RELIEF
ANADIN ULTRA
Anco
Andran
Anflagen
Apo-Ibuprofen
Apsifen
APSIFEN-F
ARTHROFEN 200
ARTHROFEN 400
ARTHROFEN 600
Artril 300
Bluton
Brufanic
Brufen
BRUFEN RET
Brufort
Buburone
Butylenin
Calcium salt ibuprofen
CALDOLOR
CAP-PROFEN
CHILDREN'S ADVIL
CHILDREN'S ADVIL-FLAVORED
CHILDREN'S ELIXSURE
CHILDREN'S IBUPROFEN
CHILDREN'S MOTRIN
CODAFEN CONTINUS
Codral
CO-OP
CUPROFEN FOR CHILD
CUPROFEN PLUS
DEEP RELIEF
Dolgin
Dolgirid
Dolgit
Dolocyl
Dolo-dolgit
Duralbuprofen
Ebufac
Emodin
Epobron
Femadon
FEMAFEN
FENBID
FENBID FTE
Fenbid Spansule
FENPAED
FEVERFEN
FLEXIMEX
Haltran
I.V. solution, ibuprofen
IB-100
Ibu
Ibu-attritin
IBUCALM
IBUDERM
IBUFAC
Ibufen
IBUGEL
IBUGEL FTE
IBULAR
IBULEVE
IBUMED
Ibumetin
IBUMOUSSE
IBUPRIN
Ibuprocin
IBUPROFEN
Ibuprofen i.v. solution
Ibuprofen zinc
|
Ibuprofen, (+-)-isomer
Ibuprofen, (R)-isomer
Ibuprofen, (S)-isomer
Ibuprofen, aluminum salt
Ibuprofen, calcium salt
Ibuprofen, copper (2+) salt
Ibuprofen, magnesium salt
Ibuprofen, potassium salt
Ibuprofen, sodium salt
Ibuprofen, zinc salt
Ibuprofene
Ibuprofeno
Ibuprofenum
Ibuprofen-zinc
IBUPROHM
IBUPROPHEN
IBU-SLO
IBUSPRAY
IBU-TAB
IBU-TAB 200
Ibutid
IBUTIME
Ifen
Inabrin
Inoven
IP 82
IP-82
ISISFEN
JUNIFEN
JUNIOR STRENGTH ADVIL
JUNIOR STRENGTH IBUPROFEN
JUNIOR STRENGTH MOTRIN
Lamidon
Lebrufen
LIDIFEN
LIDIFEN-F
Liptan
LOBUFEN
M01AE01
Magnesium salt ibuprofen
MANDAFEN
MANORFEN
MAXA-GESIC
Medipren
MIDOL
Midol 200
MIDOL LIQUID GELS
MIGRAFEN
Motrin
MOTRIN IB
MOTRIN MIGRAINE PAIN
Mynosedin
Napacetin
NeoProfen
Nobfelon
Nobfen
Nobgen
NOVAPRIN
Novogent N
Novoprofen
NSC-256857
Nuprin
Nurofen
NUROFEN 400
NUROFEN BACK PAIN SR
NUROFEN CHILD
NUROFEN FOR CHILD
NUROFEN PLUS
NUROFEN RECOVERY
NUROFEN SINUS
NUROFEN SOLB
ORBIFEN
PACIFENE
Pantrop
Para-Isobutylhydratropic Acid
PAXOFEN
PEDEA
Pediaprofen
Pedia-Profen
PEDIATRIC ADVIL
PHENSIC
PHOR PAIN
PHORPAIN
PHORPAIN MAX STRGH
p-Isobutyl-2-phenylpropionate
p-Isobutyl-2-phenylpropionic acid
p-Isobutylhydratropate
p-Isobutylhydratropic acid
Potassium salt ibuprofen
PROFEN
PROFLEX
PROFLEX SR
Rafen
RD 13621
Rebugen
RELCOFEN
RIMAFEN
Roidenin
Rufen
Salprofen
Salt ibuprofen, magnesium
Salt ibuprofen, sodium
Salt ibuprofen, zinc
Seclodin
Sodium salt ibuprofen
Suspren
Tabalon
TAB-PROFEN
Trauma dolgit gel
Trauma-dolgit gel
TraumaDolgit gel
Trendar
U-18573
Urem
Zinc salt ibuprofen
Α-(4-isobutylphenyl)propionate
Α-(4-isobutylphenyl)propionic acid
Α-(p-isobutylphenyl)propionate
Α-(p-isobutylphenyl)propionic acid
|
|
37 |
|
Diamorphine |
Approved, Illicit, Investigational |
Phase 4 |
|
561-27-3 |
5462328 |
Synonyms:
(5ALPHA,6ALPHA)-7,8-DIDEHYDRO-4,5-EPOXY-17-METHYLMORPHINAN-3,6-DIOL DIACETATE (ESTER)
(5Α,6Α)-7,8-DIDEHYDRO-4,5-EPOXY-17-METHYLMORPHINAN-3,6-DIOL DIACETATE (ESTER)
3,6-DIACETYLMORPHINE
7,8-DIHYDRO-4,5-ALPHA-EPOXY-17-METHYLMORPHINAN-3,6-ALPHA-DIOL DIACETATE
ACETOMORPHINE
DIACETYLMORPHINE
DIAMORPHINE
|
HEROIN
IDS-NH-001
IDS-NH-001(SECT.3)
J6.494G
O,O'-DIACETYLMORPHINE
Smack
|
|
38 |
|
Aspartic acid |
Approved, Nutraceutical |
Phase 4 |
|
56-84-8 |
5960 |
Synonyms:
(+)-Aspartate
(+)-Aspartic acid
(+-)-Aspartic acid
(2S)-2-AMINOBUTANEDIOIC ACID
(2S)-2-AMINOSUCCINIC ACID
(2S)-Aspartate
(2S)-Aspartic acid
(L)-Aspartate
(L)-Aspartic acid
(R)-2-Aminosuccinate
(R,S)-Aspartic acid
(S)-(+)-Aspartate
(S)-(+)-Aspartic acid
(S)-2-Aminobutanedioate
(S)-2-Aminobutanedioic acid
(S)-2-Aminosuccinate
(S)-2-Aminosuccinic acid
(S)-Aminobutanedioate
(S)-Amino-butanedioate
(S)-Aminobutanedioic acid
(S)-Amino-butanedioic acid
(S)-Aspartate
(S)-Aspartic acid
[<sup>3</sup>H]-L-aspartate|[<sup>3</sup>H]-L-aspartic acid
2-Amino-3-methylsuccinate
2-Amino-3-methylsuccinic acid
2-Aminosuccinate
2-Aminosuccinic acid
ácido aspártico
Acidum asparticum
alpha-Aminosuccinate
alpha-Aminosuccinic acid
Aminosuccinate
Ammonium aspartate
Asp
Asparagate
Asparagic acid
Asparaginate
Asparaginic acid
Asparatate
ASPARTate
Aspartate magnesium hydrochloride
Aspartate, ammonium
Aspartate, calcium
Aspartate, dipotassium
Aspartate, disodium
Aspartate, magnesium
Aspartate, monopotassium
Aspartate, monosodium
Aspartate, potassium
Aspartate, sodium
|
ASPARTIC ACID
Aspartic acid, ammonium salt
Aspartic acid, calcium salt
Aspartic acid, dipotassium salt
Aspartic acid, disodium salt
Aspartic acid, hydrobromide
Aspartic acid, hydrochloride
Aspartic acid, magnesium (1:1) salt, hydrochloride, trihydrate
Aspartic acid, magnesium (2:1) salt
Aspartic acid, magnesium-potassium (2:1:2) salt
Aspartic acid, monopotassium salt
Aspartic acid, monosodium salt
Aspartic acid, potassium salt
Aspartic acid, sodium salt
Calcium aspartate
D
Dipotassium aspartate
Disodium aspartate
FEMA NO. 3656
H-Asp-OH
Hydrobromide aspartic acid
Hydrochloride aspartic acid
Hydrochloride, aspartate magnesium
L Aspartate
L Aspartic acid
L-(+)-Aspartate
L-(+)-Aspartic acid
L-Aminosuccinate
L-Aminosuccinic acid
L-Asp
L-Asp|L-aspartate
L-Asparagate
L-Asparagic acid
L-Asparaginate
L-Asparaginic acid
L-Asparaginsaeure
L-Asparaginsäure
L-Aspartate
L-Aspartic acid
Magnesiocard
Magnesium aspartate
MG 5 Longoral
MG5Longoral
MG-5-Longoral
Monopotassium aspartate
Monosodium aspartate
NSC-3973
Poly-DL-succinimide
Polysuccinimide
Potassium aspartate
Sodium aspartate
|
|
39 |
|
Calcifediol |
Approved, Nutraceutical |
Phase 4 |
|
19356-17-3 |
5283731 |
Synonyms:
(1S,3Z)-3-{2-[(1R,3AS,4E,7AR)-1-[(2R)-6-HYDROXY-6-METHYLHEPTAN-2-YL]-7A-METHYL-OCTAHYDRO-1H-INDEN-4-YLIDENE]ETHYLIDENE}-4-METHYLIDENECYCLOHEXAN-1-OL
(3b,5Z,7E)-9,10-Secocholesta-5,7,10(19)-triene-3,25-diol
(3beta,5Z,7E)-9,10-Secocholesta-5,7,10(19)-triene-3,25-diol
(3S,5Z,7E)-9,10-Seco-5,7,10(19)-cholestatriene-3,25-diol
(3S,5Z,7E)-9,10-Secocholesta-5,7,10-triene-3,25-diol
(3Β,5Z,7E)-9,10-secocholesta-5,7,10(19)-triene-3,25-diol
(5Z,7E)-(3S)-9,10-Secocholesta-5,7,10(19)-triene-3,25-diol
25 Hydroxycholecalciferol
25 Hydroxycholecalciferol monohydrate
25 Hydroxyvitamin D 3
25 Hydroxyvitamin D3
25(OH)D
25(OH)D3
25-Hydroxycholecalciferol
25-Hydroxy-cholecalciferol
25-Hydroxycholecalciferol monohydrate
25-Hydroxyvitamin D 3
25-Hydroxyvitamin D3
3-{2-[1-(5-hydroxy-1,5-dimethyl-hexyl)-7a-methyl-octahydro-inden-4-ylidene]-ethylidene}-4-methylene-cyclohexanol
5,6-cis-25-Hydroxyvitamin D3
9,10-Secocholesta-5,7,10(19)-triene-3b,25-diol
Anhydrous, calcifediol
|
Aventis brand OF calcifediol
Calcidiol
Calcifediol
Calcifédiol
Calcifediol anhydrous
Calcifediol aventis brand
Calcifediol faes brand
Calcifediol organon brand
Calcifediol, (3 alpha,5Z,7E)-isomer
Calcifediol, (3 beta,5E,7E)-isomer
Calcifediolum
Calderol
Dedrogyl
Didrogyl
Faes brand OF calcifediol
Hidroferol
Monohydrate, 25-hydroxycholecalciferol
Organon brand OF calcifediol
Rayaldee
RYALDEE
U-32070E
|
|
40 |
|
Calcitriol |
Approved, Nutraceutical |
Phase 4 |
|
32222-06-3 |
5280453 |
Synonyms:
(1a,3b,5Z,7E)-9,10-Secocholesta-5,7,10(19)-triene-1,3,25-triol
(1alpha,3beta,5Z,7E)-9,10-Secocholesta-5,7,10(19)-triene-1,3,25-triol
(1R,3S,5Z)-5-{2-[(1R,3AS,4E,7AR)-1-[(2R)-6-HYDROXY-6-METHYLHEPTAN-2-YL]-7A-METHYL-OCTAHYDRO-1H-INDEN-4-YLIDENE]ETHYLIDENE}-4-METHYLIDENECYCLOHEXANE-1,3-DIOL
(1S,3R,5Z,7E)-9,10-Seco-5,7,10(19)-cholestatriene-1,3,25-triol
(1S,3R,5Z,7E)-9,10-Secocholesta-5,7,10-triene-1,3,25-triol
(1Α,3β,5Z,7E)-9,10-secocholesta-5,7,10(19)-triene-1,3,25-triol
(3b,5Z,7E)-9,10-Secocholesta-5,7,10(19)-trienetriol
(5Z,7E)-(1S,3R)-9,10-Secocholesta-5,7,10(19)-triene-1,3,25-triol
1 alpha, 25 Dihydroxy 20 epi vitamin D3
1 alpha, 25-Dihydroxy-20-epi-vitamin D3
1 alpha,25 Dihydroxycholecalciferol
1 alpha,25 Dihydroxyvitamin D3
1 alpha,25-Dihydroxycholecalciferol
1 alpha,25-Dihydroxyvitamin D3
1,25 Dihydroxy 20 epi vitamin D3
1,25 Dihydroxycholecalciferol
1,25 Dihydroxyvitamin D3
1,25(OH)2-20EPi-D3
1,25-DHCC
1,25-Dihydroxy-20-epi-vitamin D3
1,25-Dihydroxycholecalciferol
1,25-Dihydroxyvitamin D
1,25-Dihydroxyvitamin D3
1a,25(OH)2D3
1a,25-(OH)2D3
1a,25-Dihydroxycholecalciferol
1a,25-Dihydroxyvitamin D3
1a,25-Dihydroxyvitamin D3 / 1a,25-dihydroxycholecalciferol / calcitriol
1-a-25-Dihydroxyvitamin D3
1alpha,25(OH)2D3
1alpha,25-Dihydroxycholecalciferol
1alpha,25-Dihydroxyvitamin D3
1-alpha,25-Dihydroxyvitamin D3
1-alpha-25-Dihydroxyvitamin D3
1Α,25(OH)2D3
1Α,25-dihydroxycholecalciferol
1Α,25-dihydroxyvitamin D3
1Α,25-dihydroxyvitamin D3 / 1α,25-dihydroxycholecalciferol / calcitriol
1-Α-25-dihydroxyvitamin D3
20 Epi 1alpha,25 dihydroxycholecaliferol
20-Epi-1alpha,25-dihydroxycholecaliferol
25-Dihydroxycholecalciferol
5-{2-[1-(5-hydroxy-1,5-dimethyl-hexyl)-7a-methyl-octahydro-inden-4-ylidene]-ethylidene}-4-methylene-cyclohexane-1,3-diol
Abbott brand OF calcitriol
alpha,25-Dihydroxyvitamin D3, 1
Alphapharm brand OF calcitriol
Bocatriol
Calcijex
Calcijex®|calcitriol|Rocaltrol®
|
Calcitriol
Calcitriol abbott brand
Calcitriol alphapharm brand
Calcitriol cryopharma brand
Calcitriol galderma brand
Calcitriol gry brand
Calcitriol jenapharm brand
Calcitriol kyramed
Calcitriol kyramed brand
Calcitriol leo brand
Calcitriol medice brand
Calcitriol nefro
Calcitriol renacare brand
Calcitriol roche brand
Calcitriol-nefro
CalcitriolNefro
Calcitriolum
Cryopharma brand OF calcitriol
D3, 1 alpha,25-Dihydroxyvitamin
D3, 1,25-Dihydroxy-20-epi-vitamin
D3, 1,25-Dihydroxyvitamin
Decostriol
DIHYDROXYCHOLECALCIFEROL
DIHYDROXYVITAMIN D 3
Dihydroxyvitamin D3
Galderma brand OF calcitriol
Gry brand OF calcitriol
Hoffmann la roche brand OF calcitriol
Hoffmann-la roche brand OF calcitriol
Jenapharm brand OF calcitriol
KyraMed brand OF calcitriol
KyraMed, calcitriol
Leo brand OF calcitriol
Medice brand OF calcitriol
Osteotriol
RenaCare brand OF calcitriol
Renatriol
Ro 21-5535
RO-215535
RO-21-5535
Rocaltrol
Roche brand OF calcitriol
Silkis
Sitriol
Soltriol
Tirocal
Topitriol
Toptriol
VECTICAL
|
|
41 |
|
Arginine |
Approved, Investigational, Nutraceutical |
Phase 4 |
|
74-79-3 |
6322 |
Synonyms:
(2S)-2-Amino-5-(carbamimidamido)pentanoate
(2S)-2-Amino-5-(carbamimidamido)pentanoic acid
(2S)-2-AMINO-5-(DIAMINOMETHYLIDENEAMINO)PENTANOIC ACID
(2S)-2-AMINO-5-[(DIAMINOMETHYLIDENE)AMINO]PENTANOIC ACID
(2S)-2-Amino-5-guanidinopentanoate
(2S)-2-Amino-5-guanidinopentanoic acid
(2S)-2-AMINO-5-GUANIDINO-PENTANOIC ACID
(S)-2-Amino-5-[(aminoiminomethyl)amino]pentanoate
(S)-2-Amino-5-[(aminoiminomethyl)amino]-pentanoate
(S)-2-Amino-5-[(aminoiminomethyl)amino]pentanoic acid
(S)-2-Amino-5-[(aminoiminomethyl)amino]-pentanoic acid
(S)-2-Amino-5-guanidinopentanoate
(S)-2-Amino-5-guanidinopentanoic acid
(S)-2-Amino-5-guanidinovalerate
(S)-2-Amino-5-guanidinovaleric acid
2-Amino-5-guanidinovalerate
2-Amino-5-guanidinovaleric acid
5-[(Aminoiminomethyl)amino]-L-norvaline
Arg
Arginina
Arginine
|
Arginine hydrochloride
Arginine, L isomer
Arginine, L-isomer
DL Arginine acetate, monohydrate
DL-Arginine acetate, monohydrate
Hydrochloride, arginine
L Arginine
L-(+)-Arginine
L-a-Amino-D-guanidinovalerate
L-a-Amino-D-guanidinovaleric acid
L-alpha-Amino-delta-guanidinovalerate
L-alpha-Amino-delta-guanidinovaleric acid
L-Arg
L-Arginin
L-ARGININE
L-Isomer arginine
Monohydrate DL-arginine acetate
N5-(Aminoiminomethyl)-L-ornithine
NSC-206269
R
|
|
42 |
|
L-Glutamine |
Approved, Investigational, Nutraceutical |
Phase 4 |
|
56-85-9 |
5961 |
Synonyms:
(2S)-2,5-Diamino-5-oxopentanoate
(2S)-2,5-DIAMINO-5-OXOPENTANOIC ACID
(2S)-2-Amino-4-carbamoylbutanoate
(2S)-2-AMINO-4-CARBAMOYLBUTANOIC ACID
(S)-2,5-Diamino-5-oxopentanoate
(S)-2,5-DIAMINO-5-OXOPENTANOIC ACID
[<sup>14</sup>C]-glutamine
[<sup>3</sup>H]-glutamine
2-Aminoglutaramic acid
Cebrogen
D Glutamine
D-Glutamine
ENDARI
FEMA NO. 3684
gamma-Glutamine
Glavamin
GLN
Glumin
Glutamate 5-amide
Glutamate amide
GLUTAMIC ACID 5-AMIDE
GLUTAMIC ACID AMIDE
Glutamina
GLUTAMINE
L Glutamine
L-(+)-GLUTAMINE
|
L-2-Aminoglutaramate
L-2-AMINOGLUTARAMIC ACID
L-2-Aminoglutaramidic acid
Levoglutamid
Levoglutamida
LEVOGLUTAMIDE
Levoglutamidum
Levoglutamina
L-Glutamate g-amide
L-Glutamate gamma-amide
L-Glutamate γ-amide
L-Glutamic acid 5-amide
L-Glutamic acid g-amide
L-GLUTAMIC ACID GAMMA-AMIDE
L-GLUTAMIC ACID Γ-AMIDE
L-Glutamid
L-Glutamide
L-GLUTAMIN
L-GLUTAMINE
L-GLUTAMINSAEURE-5-AMID
L-GLUTAMINSÄURE-5-AMID
NSC-27421
NUTRESTORE
Polyglutamine
Q
Stimulina
|
|
43 |
|
Lactoferrin |
Investigational |
Phase 4 |
|
151186-19-5 |
|
Synonyms:
|
44 |
|
(3-Carboxy-2-(R)-Hydroxy-Propyl)-Trimethyl-Ammonium |
Experimental |
Phase 4 |
|
461-06-3 |
|
Synonyms:
CARNITINE
CARNITINE CHLORIDE
|
|
|
45 |
|
N-Methylaspartate |
|
Phase 4 |
|
|
|
46 |
|
Hydroxycholecalciferols |
|
Phase 4 |
|
|
|
47 |
|
Chondroitin |
|
Phase 4 |
|
9007-27-6 |
14389182 |
Synonyms:
2-Acetamido-2-deoxy-3-O-b-D-glucopyranuronosyl-b-D-galactopyranose
2-Acetamido-2-deoxy-3-O-beta-D-glucopyranuronosyl-beta-D-galactopyranose
2-Acetamido-2-deoxy-3-O-β-D-glucopyranuronosyl-β-D-galactopyranose
b-D-GlcA-(1->3)-b-D-galnac
b-D-GlcpA-(1->3)-b-D-galpnac
b-D-Glucuronosyl-(1->3)-2-acetamido-2-deoxy-b-D-galactose
beta-D-GlcA-(1->3)-beta-D-galnac
|
beta-D-Glucuronosyl-(1->3)-2-acetamido-2-deoxy-beta-D-galactose
Chondroitin
Chondroitin-D-glucuronate
N-Acetylchondrosine
Β-D-glca-(1->3)-β-D-galnac
Β-D-glcpa-(1->3)-β-D-galpnac
Β-D-glucuronosyl-(1->3)-2-acetamido-2-deoxy-β-D-galactose
|
|
48 |
|
Zinc Supplement |
|
Phase 4 |
|
|
|
49 |
|
Teferrol |
|
Phase 4 |
|
|
|
50 |
|
Caseins |
|
Phase 4 |
|
|
|
Interventional clinical trials:
(show top 50)
(show all 3341)
# |
Name |
Status |
NCT ID |
Phase |
Drugs |
1 |
The Role Of IV Iron (Ferric Carboxymaltose) And IM Vitamin B12 (Hydroxycobalamin) Supplementation In The Management Of Anaemic Prevalent Indian Hemodialysis Patients: A Parallel Group, Quadruple Blind, Placebo-Controlled, Pragmatic Randomized Control Trial With 2x2 Factorial Design |
Unknown status |
NCT04627181 |
Phase 4 |
Ferric carboxymaltose;Hydroxycobalamin;Placebo |
2 |
A Multi-Center, Randomized, Open Label Trial to Evaluate the Utility of Serum Hepcidin Levels to Predict Response to Oral or IV Iron and Compare the Safety, Effect on Quality of Life, and Resource Utilization of Injectafer vs. Intravenous Iron Standard of Care for the Treatment of Iron Deficiency Anemia (IDA) in an Infusion Center Setting |
Unknown status |
NCT01950247 |
Phase 4 |
Injectafer;SOC |
3 |
Effectiveness of Weekly and Daily Iron Supplementation for the Prevention of Iron-deficiency Anemia in Infants. Impact on Genomic Stability |
Unknown status |
NCT03359447 |
Phase 4 |
Weekly Ferrous Sulfate;Daily Ferrous Sulfate |
4 |
Different Doses of Anti-thymocyte Globin With 2.5 or 3.75mg/kg to Treat Child Severe Aplastic Anemia |
Unknown status |
NCT01997372 |
Phase 4 |
ATG |
5 |
Does Eradication of H-pylori in Pregnant Patients With Iron Deficiency Anemia Have an Effect on Iron Replacement Therapy? |
Unknown status |
NCT03347513 |
Phase 4 |
triple attack therapy;Ferrous(II)-glycine-sulphate complex 567.7 mg capsules |
6 |
Randomized Cross-Over Trial of Captafer® vs. Oral Iron Sulfate in the Treatment of Iron Deficiency Anemia in Patients With Inflammatory Bowel Disease |
Unknown status |
NCT02774057 |
Phase 4 |
Captafer®;Iron Sulfate |
7 |
Moderate-dose Cyclophosphamide for Childhood Acquired Aplastic Anemia |
Unknown status |
NCT01995331 |
Phase 4 |
cyclophosphamide,cyclosporine A |
8 |
Amino Acid Chelated Iron Versus Ferrous Fumarate in the Treatment of Iron Deficiency Anemia With Pregnancy: Randomized Controlled Trial |
Unknown status |
NCT03830034 |
Phase 4 |
Amino Acid chelated iron tab 15 mg;Ferrous Fumarate tab 350 mg( 115 mg elemental iron) |
9 |
The Impact of Treatment of Anaemia With Intravenous Iron on Haematological Values for Patients After Colorectal Surgery |
Unknown status |
NCT02999217 |
Phase 4 |
Iron isomaltoside;Saline |
10 |
Tacrolimus Treatment for Refractory Autoimmune Cytopenia |
Unknown status |
NCT03918265 |
Phase 4 |
Tacrolimus |
11 |
Effektivität Der in Der Schwangerschaftsvorsorge routinemässig Angewandten Eisenprophylaxe |
Unknown status |
NCT02487719 |
Phase 4 |
Iron sulfate and Iron polymaltose for prevention of iron deficiency anemia |
12 |
Randomized, Parallel Group, Clinical Trial Comparing Intravenous Iron Sucrose Versus Oral Ferrous Sulphate in the Treatment of Perioperative Iron Deficiency in Patients With Colo-Rectal Neoplasm and Iron Deficiency Anemia. |
Unknown status |
NCT00199277 |
Phase 4 |
i.v. iron sucrose;Oral iron |
13 |
Long-term Safety and Efficacy Study of Ferriprox® for the Treatment of Transfusional Iron Overload in Patients With Sickle Cell Disease or Other Anemias |
Unknown status |
NCT02443545 |
Phase 4 |
Deferiprone |
14 |
Bovine Lactoferrin Versus Ferrous Sulphate In The Treatment Of Iron Deficiency Anemia During Pregnancy: A Randomized Controlled Trial |
Unknown status |
NCT03202615 |
Phase 4 |
F (ferrous sulphate) |
15 |
Multi-center Clinical Study of Immunosuppressants, Cyclophosphamide, And Cord Blood Transfusion in Treating Patients With Severe Aplastic Anemia |
Unknown status |
NCT02838992 |
Phase 4 |
Rabbit ATG, (Genzyme);Cy;CsA |
16 |
the Effectiveness of Lactoferrin in Treatment of Iron Deficiency Anemia in Children With Chronic Tonsillitis |
Unknown status |
NCT03748043 |
Phase 4 |
Lactoferrin;Ferric Hydroxide Polymaltose |
17 |
Phase 4 Study on the Efficacy of Erythropoietin Treatment in Patients With Systolic Left Ventricular Dysfunction, Mild Anemia and Normal Renal Function |
Unknown status |
NCT00418119 |
Phase 4 |
erythropoietin |
18 |
Ferritin Screening And IRon Treatment for Maternal Anemia and Fetal Growth Restriction (FGR) Prevention - a Multi Centre Randomised Controlled Trial (RCT) |
Unknown status |
NCT04228627 |
Phase 4 |
Parentral Iron |
19 |
Anemia Treatment in Inflammatory Bowel Disease: Predictive Factors of Response to Oral Iron Treatment |
Unknown status |
NCT02760940 |
Phase 4 |
oral liposomal iron |
20 |
Efficacy and Safety of Erythropoietin in the Treatment of Anemia in Patients With Lymphoma After Autologous Hematopoietic Stem Cell Transplantation |
Unknown status |
NCT03010579 |
Phase 4 |
erythropoietin;iron supplementation |
21 |
Investigation of Signal Pathway Induced by Colla Corri Asini Regulating Globin Level in Beta Thalassemia Patients With Pregnancy Anemia |
Unknown status |
NCT03392298 |
Phase 4 |
Colla corii asini |
22 |
Intravenous Iron Isomaltoside 1000 (Monofer®) Compared With Oral Iron in the Treatment of Postgastrectomy Anemia: An Open-label Randomized Controlled Trial |
Unknown status |
NCT03229954 |
Phase 4 |
iron isomaltoside (Monofer) intravenous infusion;Ferrous sulfate(Feroba-YOU) per oral |
23 |
Efficacy and Safety of Intravenous Iron Sucrose in Patients With Hip Fracture to Prevent Perioperative Anemia |
Unknown status |
NCT01084122 |
Phase 4 |
Iron sucrose |
24 |
Treatment of Anemia in the 2nd Year of Life. Comparison of the Efficacy of Two Different Iron Preparations. |
Unknown status |
NCT00248716 |
Phase 4 |
Ferrous gluconate and iron polysaccharide complex |
25 |
A Multi-center Randomized, Double-blind, Placebo-controlled Study of Colla Corii Asini for the Treatment of Anemia in Pregnant Women With Thalassemia(Presenting the Syndrome of Blood Deficiency) |
Unknown status |
NCT03374111 |
Phase 4 |
Colla corii asini;a Simulate Agent of Colla corii asini granule |
26 |
Evaluation of the Efficacy in Decreasing Iron Absorption in Patients With Congenital Dyserythropoietic Anemia Type I by Treatment With LOSEC |
Unknown status |
NCT01795794 |
Phase 4 |
omeprazole |
27 |
Child With Severe Aplastic Anemia (SAA) Therapy: the Injection of Umbilical Cord Derived Mesenchymal Stem Cells. |
Unknown status |
NCT02218437 |
Phase 4 |
MSC+ATG |
28 |
Preoperative, Single-dose Intravenous Iron Formulation to Reduce Post-surgical Complications in Patients Undergoing Major Abdominal Surgery: a Pilot Randomised Control Trial (PIRCAS Trial - Pilot) |
Unknown status |
NCT03295851 |
Phase 4 |
Ferric carboxymaltose;Ferrous Fumarate |
29 |
The Potential Hepatoprotective Effect of Metformin in Patients With Beta Thalasemia Major |
Unknown status |
NCT02984475 |
Phase 4 |
Metformin |
30 |
An Pilot Study to Assess the Efficacy of Intravenous Iron Isomaltoside 1000 (Monofer®) in the Management of Anaemia Associated With the Palliative Management of Oesophagogastric Adenocarcinoma |
Unknown status |
NCT01927328 |
Phase 4 |
Iron isomaltoside 1000 |
31 |
Effectiveness of Iron Supplementation in the Second Year of Life for Prevention of Iron Deficiency |
Unknown status |
NCT00479102 |
Phase 4 |
Ferripel-3 - iron polysaccharide complex for prevention |
32 |
Multicenter Randomized Controlled Trial Comparing Ferric(III)Carboxymaltose Infusion With Oral Iron Suppletion in the Treatment of Preoperative Anaemia in Colorectal Cancer Patients |
Unknown status |
NCT02243735 |
Phase 4 |
Ferrous fumarate;ferric(III)carboxymaltose |
33 |
A Randomized Controlled Trial of Oral and Intravenous Tranexamic Acid in Lumbar Spine Surgery |
Unknown status |
NCT03037515 |
Phase 4 |
Tranexamic Acid |
34 |
Effect of Postoperative Ferric Carboxymaltose After Simultaneous Bilateral Total Knee Arthroplasty : A Randomized, Controlled, Double-Blind Trial |
Unknown status |
NCT03561480 |
Phase 4 |
Ferric carboxymaltose;0.9% Normal Saline |
35 |
Evaluation of the Effects of L-Carnitine Injection in Patients Undergoing Hemodialysis |
Unknown status |
NCT00173706 |
Phase 4 |
L-Carnitine Injection |
36 |
Intermittent Treatment With Sulfadoxine-Pyrimethamine for Malaria Control in Children: A Randomised, Double Blind, and Placebo-Controlled Clinical Trial |
Unknown status |
NCT00168948 |
Phase 4 |
Sulfadoxin (12.5) Pyrimethamine (250 mg) |
37 |
The Effects of Acetylcysteine on Alleviating Damage of Oxidative Stress in Hemodialysis Patients |
Unknown status |
NCT00247507 |
Phase 4 |
acetylcysteine |
38 |
Effect of Preoperative Ferric Carboxymaltose After Simultaneous Bilateral Total Knee Arthroplasty : A Randomized, Controlled, Double-Blind Trial |
Unknown status |
NCT03561506 |
Phase 4 |
Ferric carboxymaltose;0.9% Normal Saline |
39 |
The Effect of a Nutrient Fortified Oat Drink on Iron, Zinc, Vitamin A, and Vitamin C Status Among Filipino Children |
Unknown status |
NCT01418898 |
Phase 4 |
|
40 |
The Impact of Intermittent Preventive Malaria Treatment With Artemisinin Combination Therapy (ACT) on Hemoglobin, Malaria, Schistosomiasis, and School Attention Among Primary Schoolchildren in the Kassena-Nankana Districts, Ghana |
Unknown status |
NCT01459146 |
Phase 4 |
Artemether-lumefantrine combination plus albendazole;Artemether-lumefantrine plus Praziquantel plus Albendazole;Albendazole plus Praziquantel |
41 |
The Effect of Intra Venus Ferric Carboxymaltose Preoperative on Hemoglobin and Blood Transfusion Post Cardiac Surgery |
Unknown status |
NCT02939794 |
Phase 4 |
Ferinject;Placebo |
42 |
Effect of Iron Supplementation on Psychomotor Development of Non-anemic Exclusively or Predominantly Breastfed Infants: Randomized, Double-blind, Placebo-controlled Trial. |
Unknown status |
NCT02242188 |
Phase 4 |
Iron |
43 |
A Randomized, Double-blind, Multi-center Clinical Trial Prospectively Evaluating Iron Protein Succinylate Oral Solution in Treating Patients With Chronic Heart Failure and Iron Deficiency |
Unknown status |
NCT03344523 |
Phase 4 |
Iron protein succinylate oral solution |
44 |
Combination With Intravenous Iron Supplementation or Doubling Erythropoietin Dose for Patients With Chemotherapy-induced Anaemia Inadequately Responsive to Initial Erythropoietin Treatment Alone |
Unknown status |
NCT02731378 |
Phase 4 |
Erythropoietins (EPO);Aggressive iron dextran supplementation;Sustained iron dextran supplementation |
45 |
Endothelial Monocyte-activating Polypeptide-II as an Endothelial Dysfunction Marker and Its Relation to the Oxidative Stress in Egyptian Sickle Patients |
Unknown status |
NCT03903133 |
Phase 4 |
Vitamin E |
46 |
a Randomized Control Trial to Assess the Effect of Early vs Routine Iron Supplementation on Iron Store and Growth in Term Small for Gestational Age and Appropriate for Gestational Age Infants at 1 Year |
Unknown status |
NCT03171324 |
Phase 4 |
Iron Supplement |
47 |
Iron Deficiency as an Ignored Cause of Infertility |
Unknown status |
NCT04510870 |
Phase 4 |
Ferric Carboxymaltose Injection;NaCl infusion |
48 |
Effect of Mobile-Directly Observed Therapy (DOT) on Adherence to Hydroxyurea Treatment in Adult HbSS Patients at Muhimbili National Hospital (MNH) in Tanzania: a Pilot Study |
Unknown status |
NCT02844673 |
Phase 4 |
Hydroxyurea |
49 |
Megadose of Hydroxocobalamin (Vitamin B12) for the Treatment of Pernicious Anemia |
Completed |
NCT03372447 |
Phase 4 |
Hydroxocobalamin 10,000mcg, Thiamin 100mg, Pyridoxine 50mg |
50 |
A Randomized Phase IV Control Trial of Single High Dose Oral Vitamin D3 (Stoss Therapy) in Pediatric Patients Undergoing HSCT to Prevent Vitamin D Deficiency and Insufficiency During Transplant |
Completed |
NCT03176849 |
Phase 4 |
|
Inferred drug relations via
UMLS
71
/
NDF-RT
50
:
darbepoetin alfa
Epoetin Alfa
Nandrolone
nandrolone decanoate
|
nandrolone phenpropionate
Oxymetholone
Sodium Ascorbate
|
Cochrane evidence based reviews: anemia
|